Date: 2015-05-06
Type of information: Nomination
Compound:
Company: Lundbeck (Denmark)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On May 6, 2015, Lundbeck announced that the Board of Directors of the company has appointed Kåre Schultz as new president and CEO of Lundbeck. Kåre Schultz will take up his new position on 20 May 2015. Lundbeck\'s future president and CEO has been the president and COO of Novo Nordisk A/S since January 2014. He joined Novo Nordisk in 1989. Kåre Schultz is chairman of the board of Royal Unibrew A/S and a member of the board of LEGO A/S, both in Denmark. He has an MSc in Economics from the University of Copenhagen, Denmark, from 1987. Kåre Schultz is a Danish national, born May 1961.
Financial terms:
Latest news:
